Trials / Completed
CompletedNCT02377024
Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Functions
Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Functions in Healthy Adults With Subjective Cognitive Impairment: An 8-Week Prospective Randomized Double-Blind Placebo-Controlled Trial With Multimodal Neuroimaging and Neurocognitive Assessments
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Ewha Womans University · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to demonstrate the cognitive enhancement effect and safety of Tremella Fuciformis, using the cognitive and clinical indicators (e.g. memory, attention, and psychomotor speed) and the latest brain imaging methods for healthy adults suffering subjective cognitive impairment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | TF 600mg | |
| DIETARY_SUPPLEMENT | TF 1200mg | |
| DIETARY_SUPPLEMENT | placebo |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2015-03-03
- Last updated
- 2015-07-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02377024. Inclusion in this directory is not an endorsement.